elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36222681-00DF4280-2422-44BA-BF66-ACFD6D80F17D
Q36222681-00DF4280-2422-44BA-BF66-ACFD6D80F17D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36222681-00DF4280-2422-44BA-BF66-ACFD6D80F17D
Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia.
P2860
Q36222681-00DF4280-2422-44BA-BF66-ACFD6D80F17D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36222681-00DF4280-2422-44BA-BF66-ACFD6D80F17D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f954dd99134835f326e1401154ef2d1c35ea18c
P2860
Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria